Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6X7D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,682
Award facts
- Contract value 100% obligated
- $13,682.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13.68K firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Vraylar 1.5 mg capsules (30-count) to support federal medical procurement needs. The contract, with an ultimate completion date of January 23, 2026, represents a non-set-aside, competitively awarded task order issued under a larger Indefinite Delivery Contract vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, and this delivery order will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania.
This delivery order falls under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent company Cencora, Inc. holds an even larger IDC with DLA valued up to $999.99M through December 31, 2031, enabling the supply of a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6X7D?
SPE2DR26F6X7D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F6X7D worth?
The government has obligated $13,682 on SPE2DR26F6X7D.
Is contract SPE2DR26F6X7D an order under another contract?
Yes. SPE2DR26F6X7D is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X7D competed?
The extent of competition for SPE2DR26F6X7D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award